As such, evidence suggests that glutamate released by GBM glioma cells may be able to promote pro-migration/invasion and proliferative effects through seizure-induced alterations to the functionality of GLT-1, NMDARs, and AMPARs. Here, SLC1A2 is linked to central nervous system cancer.